Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Certain medicationsincluding proton pump inhibitors, metformin, and some anticonvulsantsmay affect the absorption or metabolism of specific nutrients
For subcutaneous injection, the peptide is injected into the fatty tissue layer beneath the skin
Research progress Support The animal experiments have achieved remarkable results: In the obese mouse model, after daily subcutaneous injection of AOD 9604 (250 g/kg) for 8 weeks, the body weight of the mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue significantly decreased, confirming its effectiveness in fat reduction
Tesamorelin, a growth hormone-releasing hormone (GHRH) analog, appears to act by binding to and activating the GHRH receptor on somatotrophs in the pituitary gland
Another study conducted in 2018 demonstrated that the combination of Phosphatidylcholine (PC) and Deoxycholate (DC) effectively reduced unwanted fat in the body
The choice among agents depends on factors including dosing frequency (daily versus weekly), route of administration, insurance coverage, patient preference, and comorbidity profile
